|  Nevada                    |   | 98-0377767          |
|---------------------------------|--------|---------------------|
| (State or Other Jurisdiction of |   | (IRS Employer       |
| Incorporation or Organization)  |   | Identification No.) |

| Ben Gurion Street 1, Bnei Brak, Israel   |   | 23840      |
|------------------------------------------|--------|------------|
| (Address of Principal Executive Offices) |   | (Zip Code) |

| 972-73-7963851                                             |
|------------------------------------------------------------|
| (Registrant’s Telephone Number, Including Area Code) |

| 18 Halivne Street, Timrat, Israel                                                  |
|------------------------------------------------------------------------------------|
| (Former Name, Former Address and Former Fiscal year, if changed since last report) |

| Large accelerated filer o |   | Accelerated filer o              |
|--------------------------------|--------|---------------------------------------|
| Non-accelerated filer o   |   | Smaller reporting company þ |

----

----

| PART I. FINANCIAL INFORMATION                                                                            |   |   |
|----------------------------------------------------------------------------------------------------------|--------|--------|
| Item 1. Financial Statements                                                                        |   | 3      |
| Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations |   | 15     |
| Item 3. Quantitative and Qualitative Disclosures about Market Risk                                  |   | 21     |
| Item 4T. Controls and Procedures                                                                    |   | 21     |
| PART II. OTHER INFORMATION                                                                               |   |   |
| Item 1. Legal Proceedings                                                                           |   | 23     |
| Item 1A. Risk Factors                                                                               |   | 23     |
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds                                 |   | 23     |
| Item 3. Defaults Upon Senior Securities                                                             |   | 23     |
| Item 4. [Removed and Reserved]                                                                      |   | 23     |
| Item 5. Other Information                                                                           |   | 23     |
| Item 6. Exhibits                                                                                    |   | 23     |
| Signatures                                                                                               |   | 24     |
| Exhibit Index                                                                                            |   | 25     |
| Certification of CEO Pursuant to Section 302                                                             |   |   |
| Certification of CFO Pursuant to Section 302                                                             |   |   |
| Certification Pursuant to U.S.C. Section 1350                                                            |   |   |

----

| Item 1. | Financial Statement (Unaudited) |
|--------------|---------------------------------|

| PART I - FINANCIAL INFORMATION                                                                                             | PAGE                                                                            |
|----------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------|
|                                                                                                                       |                                                                            |
| Item 1 – INTERIM  CONSOLIDATED FINANCIAL STATEMENTS         (UNAUDITED) |                                                                            |
|                                                                                                                       |                                                                            |
|                                                                                                                       | Balance Sheets -                                                                |   |
|                                                                                                                       |   September 30, 2011 and December 31, 2010                                 | 2 |
|                                                                                                                       |                                                                            |   |
|                                                                                                                       | Statements of Operations -                                                      |   |
|                                                                                                                       | Nine and three months ended September 30, 2011 and 2010 and from inception date | 3 |
|                                                                                                                       |                                                                            |   |
|                                                                                                                       | Statements of Cash Flows -                                                      |   |
|                                                                                                                       | Nine months ended September 30, 2011 and 2010 and from inception date           | 4 |
|                                                                                                                       |                                                                            |   |
|                                                                                                                       | Notes to the Financial Statements                                               | 5-11 |
|                                                                                                                       |                                                                            |   |

----

----

|                                                                                                                                                                                              | As ofSeptember 30, |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|
|                                                                                                                                                                                              | 2011               |   | 2010 |
|                                                                                                                                                                                              | (Unaudited)        |   | (Audited) |
|  ASSETS                                                                                                                                                                                      |               |   |   |
|                                                                                                                                                                                              |               |   |   |
| CURRENT ASSETS:                                                                                                                                                                                   |               |   |   |
|                                                                                                                                                                                              |               |   |   |
| Cash and cash equivalents                                                                                                                                                                         | 207                |   | 7,429 |
| Trade receivables                                                                                                                                                                                 | 455                |   | 1,067 |
| Accounts and other receivables                                                                                                                                                                    | 36,425             |   | 27,259 |
|                                                                                                                                                                                              |               |   |   |
| TOTAL CURRENT ASSETS                                                                                                                                                                              | 37,087             |   | 35,755 |
|                                                                                                                                                                                              |               |   |   |
| PROPERTY AND EQUIPMENT, NET                                                                                                                                                                       | 8,132              |   | 15,980 |
|                                                                                                                                                                                              |               |   |   |
| TOTAL ASSETS                                                                                                                                                                                      | 45,219             |   | 51,735 |
|                                                                                                                                                                                              |               |   |   |   |
|  LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY)                                                                                                                                           |               |   |   |
|                                                                                                                                                                                              |               |   |   |
|  CURRENT LIABILITIES:                                                                                                                                                                        |               |   |   |
|  Accounts payable and other current liabilities                                                                                                                                              |  35,467       |   |   418,109 |
|  TOTAL CURRENT LIABILITIES                                                                                                                                                                   |  35,467       |   |  418,109 |
|                                                                                                                                                                                              |               |   |   |   |
|  LONG-TERM LIABILITIES:                                                                                                                                                                      |               |   |   |   |
|  Convertible promissory notes (Note 5)                                                                                                                                                       | -                  |   |   183,178 |
|  TOTAL  LIABILITIES                                                                                                                                                                     |  35,467       |   |  601,287 |
|                                                                                                                                                                                              |               |   |   |   |
|  COMMITMENTS (Notes 3 and 6)                                                                                                                                                                 |               |   |   |   |
|                                                                                                                                                                                              |               |   |   |   |
|  SHAREHOLDERS' EQUITY (DEFICIENCY):                                                                                                                                                          |               |   |   |   |
|  Share capital -                                                                                                                                                                             |               |   |   |   |
|  Common stock of $ 0.001 par value –700,000,000 shares authorized; 193,487,806 and 68,824,268 shares issued and outstanding as of September 30, 2011 and as of December 31, 2010. |  193,487      |   |   68,823 |
|  Additional paid-in capital                                                                                                                                                                  |  4,098,914    |   |   3,846,133 |
|  Accumulated deficit during the development stage                                                                                                                                            |  (4,282,649)  |   |  (4,464,508) |
|                                                                                                                                                                                              |               |   |   |   |
|  TOTAL SHAREHOLDERS' EQUITY (DEFICIENCY)                                                                                                                                                     |  9,752        |   |  (549,552) |
|  TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIENCY)                                                                                                                                     |  45,219       |   |  51,735 |
|                                                                                                                                                                                              |               |   |   |   |
|                                                                                                                                                                                              |               |   |   |   |

----

----

|                                                                    |   |          |   |               |   |                    |   |                        |   | Inception         |
|-------------------------------------------------------------------------|--------|---------------|--------|--------------------|--------|-------------------------|--------|-----------------------------|--------|-------------------|
|                                                                    |   |  For the |   |  For the      |   |  For the           |   |  For the               |   | through           |
|                                                                    |   | Three Months  |   | Three Months  |   | NineMonths         |   | Nin Months             |   | May 22, 2002 to   |
|                                                                    |   | September     |   |  September    |   |   September   |   |    September |   | September         |
|                                                                    |   | 30, 2011      |   |  30, 2011     |   |   30, 2011    |   |   30, 2011        |   | 30, 2011          |
|                                                                    |   | (unaudited)   |   |  (unaudited)  |   |   (unaudited) |   |  (unaudited)      |   | (unaudited)       |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
|  Revenues                                                          |   | - . -         |   | 14,639             |   | 3,300                   |   | 74,015                      |   |  227,803     |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
|  Costs and expenses:                                               |   |          |   |               |   |                    |   |                        |   |              |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Research and development                                                |   | 3,117         |   | (4,737)            |   | 168                     |   | (64,856)                    |   | (585,401)         |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Sales and marketing                                                     |   | - . -         |   | - . -              |   | - . -                   |   | (4,215)                     |   |  (324,350)   |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| General and administrative                                              |   | 24,175        |   | (76,624)           |   | (85,133)                |   | (214,175)                   |   |  (3,642,525) |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Impairment of Intangible assets                                         |   | - . -         |   | - . -              |   | - . -                   |   | - . -                       |   |  (62,507)    |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Total operating income (expenses)                                       |   | 27,292        |   | (81,361)           |   | (84,965)                |   | (283,246)                   |   | (4,614,783)       |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Operating income (loss)                                                 |   | 27,292        |   | (66,722)           |   | (81,665)                |   | (209,231)                   |   | (4,386,980)       |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Interest and other income (expenses),   net                   |   | 874           |   | (12,473)           |   | (35,476)                |   | (7,975)                     |   | (126,643)         |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Income from forgiveness of debts (Note 5b and Note 7b)                  |   |  264,000 |   | - . -              |   | 299,000                 |   | - . -                       |   | 299,000           |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Income (Loss) before taxes on income                                    |   | 292,166       |   | (79,195)           |   | 181,859                 |   | (217,206)                   |   | (4,214,623)       |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Taxes on income                                                         |   | - . -         |   | - . -              |   | - . -                   |   | - . -                       |   | (68,026)          |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Net  income (loss) for the period                                  |   | 292,166       |   | (79,195)           |   | 181,859                 |   | (217,206)                   |   | (4,282,649)       |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Basic and diluted net loss per common share                             |   | (0.00)        |   | (0.00)             |   | (0.00)                  |   | (0.00)                      |   | (0.08)            |
|                                                                    |   |          |   |               |   |                    |   |                        |   |              |
| Number of shares used in computing basic and diluted net loss per share |   | 193,487,806   |   | 67,823,725         |   | 193,487,806             |   | 68,108,991                  |   | 193,487,806       |

----

----

|                                                                                                                                                                                                                                                                          |               | For the Nine Months EndedSeptember 30, |   | Cumulative from Inception (May 22, 2002) to September 30, |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------|----------------------------------------|--------|-----------------------------------------------------------|
|                                                                                                                                                                                                                                                                          |               | 2011                                   |   | 2010                                                      |   | 2011 |
|                                                                                                                                                                                                                                                                          |               | (Unaudited)                            |   | (Unaudited)                                               |
| CASH FLOWS FOR OPERATING ACTIVITIES:                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| Net income (loss) for the period                                                                                                                                                                                                                                              |               | 181,859                                |   | (217,206)                                                 |   | (4,282,649) |
| Adjustments to reconcile net loss to net cash used in operating activities:                                                                                                                                                                                                   |               |                                   |   |                                                      |   |   |
| Services contributed by officers                                                                                                                                                                                                                                              |               | - . -                                  |   | - . -                                                     |   |  3,500 |
| Depreciation and amortization                                                                                                                                                                                                                                                 |               | 7,848                                  |   | 20,010                                                    |   |  258,859 |
| Expenses for beneficial conversion feature                                                                                                                                                                                                                                    |     | 38,692                                 |   | - . -                                                     |   | 218,370 |
| Stock-based compensation                                                                                                                                                                                                                                                      |               | 11,672                                 |   | 17,508                                                    |   |  1,118,263 |
| Income from settlement of liability                                                                                                                                                                                                                                           |               | (299,000)                              |   | - . -                                                     |   | (299,000) |
| Changes in assets and liabilities:                                                                                                                                                                                                                                            |               |                                   |   |                                                      |   |   |
| Decrease (Increase) in trade receivables                                                                                                                                                                                                                                      |               | 612                                    |   | (16,011)                                                  |   | (455) |
| Increase in accounts expenses and other receivables                                                                                                                                                                                                                           |               | (9,167)                                |   | (15,227)                                                  |   | (36,426) |
| Increase (Decrease) in accounts payable and other currents                                                                                                                                                                                                                    |               | (99,644)                               |   | 93,113                                                    |   | 318,467 |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| Net cash used in operating activities                                                                                                                                                                                                                                         |               | (167,128)                              |   | (117,813)                                                 |   | (2,701,071) |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| CASH FLOWS FOR INVESTING ACTIVITIES:                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| Purchase and production of property and equipment                                                                                                                                                                                                                             |               | - . -                                  |   | (1,222)                                                   |   | (146,991) |
| Increase in long-term bank deposits                                        |               | - . -                                  |   | (3,401)                                                   |   | - . - |
| Purchase of intangible assets                                                                                                                                                                                                                                                 |               | - . -                                  |   | - . -                                                     |   | (120,000) |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| Net cash used in investing activities                                                                                                                                                                                                                                         |               | - . -                                  |   | (4,623)                                                   |   | (266,991) |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES:                                                                                                                                                                                                                                         |               |                                   |   |                                                      |   |   |
| Increase (Decrease) in convertible promissory note                                                                                                                                                                                                                            |               | (1,096)                                |   | 77,500                                                    |   |  (1,096) |
| Proceeds from issue of common stock                                                                                                                                                                                                                                           |               | 161,000                                |   | 25,000                                                    |   | 3,207,905 |
| Short-term bank credit                                                                                                                                                                                                                                                        |               | 2                                      |   | (795)                                                     |   | - . - |
| Offering costs                                                                                                                                                                                                                                                                |               | - . -                                  |   | - . -                                                     |   | (238,540) |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| Net cash provided by financing activities                                                                                                                                                                                                                           |               | 159,906                                |   | 101,705                                                   |   | 2,968,269 |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
| Increase (Decrease) in cash and cash equivalents                                                                                                                                                                                                                              |               | (7,222)                                |   | (20,731)                                                  |   | 207 |
| Cash and cash equivalents at the beginning of the period                                                                                                                                                                                                                      |               | 7,429                                  |   | 25,812                                                    |   | - . - |
| Cash and cash equivalents at the end of the period                                                                                                                                                                                                                            |               | 207                                    |   | 5,081                                                     |   |  207 |
|                                                                                                                                                                                                                                                                          |               |                                   |   |                                                      |   |   |
|  APPENDIX A -                                                                                                                                                                                                                                                            |               |                                   |   |                                                      |   |   |
|  Supplemental disclosure of non-cash financing activities and cash flow information:                                                                                                                                                                                     |               |                                   |   |                                                      |   |   |
|  Conversion of shareholders' loans to equity                                                                                                                                                                                                                             |               |  19,000                           |   | -                                                         |   |  19,000 |
|  Conversion of convertible promissory note to equity                                                                                                                                                                                                                     |               |  186,774                          |   | -                                                         |   |   186,774 |

----

----

|   |   |
|--------|--------|

| a.   | General |
|----------------|---------|

|   |   |
|--------|--------|

| b.   | Going concern |
|----------------|---------------|

| c.   | On July 5, 2011 the Company entered into a share purchase agreement, See also Note 7b. |
|----------------|----------------------------------------------------------------------------------------|

----

----

| a.   | Basis of Presentation |
|----------------|-----------------------|

| b.   | Use of Estimates |
|----------------|------------------|

| c.   | Financial Statements in U.S. dollars |
|----------------|--------------------------------------|

| d.   | Principles of Consolidation |
|----------------|-----------------------------|

----

----

|   |   |
|--------|--------|

|   |   |
|--------|--------|

|   |   |
|--------|--------|

| e.   | Convertible debt with beneficial conversion feature |
|----------------|-----------------------------------------------------|

|   |   |
|--------|--------|

|   |   |
|--------|--------|

| f.   | Exchange Rates |
|----------------|----------------|

|   | Exchange and linkage differences are charged or credited to operations as incurred. |
|--------|-------------------------------------------------------------------------------------|

|   |   |
|--------|--------|

|   | Exchange rates: |
|--------|-----------------|

|                          |   | September 30,                                                  |   | December 31, |
|-------------------------------|--------|----------------------------------------------------------------|--------|--------------|
|                          |   | 2011                                                           |   | 2010         |
| New Israeli Shekel (NIS)      |   | $ 0.269                                                        |   | $ 0.282      |
|                          |   |                                                           |   |         |
|                          |   |      Nine  Months Ended September 30, |
| Decrease in Rate of Exchange: |   | 2011                                                           |   | 2010         |
| NIS                           |   | (4.6%)                                                         |   | (3.0%)       |

| g.   | Implementation of New Accounting Standards |
|----------------|--------------------------------------------|

----

----

----

----

| a.   | On February 22, 2009, the Company received an interest free loan in the amount of $93,274 in the form of a convertible promissory note with BioTech Knowledge LLC, convertible to up to 11,659,250 shares of the Company's common stock, at a price of $0.008 per share, within 12 months from the closing date, with each share of common stock such converted awarding a warrant to purchase one share of the Company’s common stock at the price per share of $0.016 exercisable within three years. During years 2009, 2010 and 2011, the Company received from Bio Tech Knowledge LLC additional interest free loans, with the same terms, in an aggregate amount of $92,500. The loans are convertible to up to 11,562,500 shares of the Company's common stock, at a price of $0.008 per share, within 12 months from the date of the grant, with each share of common stock such converted awarding a warrant to purchase one share of the Company’s common stock at the price per share of $0.016 exercisable within three years. |
|----------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b.   | On April 1, 2010, the Company received a loan from Lindon Group Inc., Rhode Island Corporation (which is a related party of one of the company's major customers) in the amount of $35,000, bearing a yearly interest of 6%, in the form of a promissory note. This loan was forgiven by Lindon group on March 8, 2011, along with terminating its distribution agreement with the Company. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

| a. | On April 14, 2011 a loan agreement was signed with Oren Fuerst and Noam Yellin (the lenders), according to which  the company was to receive a loan of an aggregated amount of $53,000. ($26,500 from each), in a form of convertible promissory note. As of May 23, 2011 the company received only $19,000. The lenders decided to withdraw from the agreement and not to lend the rest of the money to the company. Therefore the company board of directors decided to cancel the agreement with the lenders. On July 26, 2011, as part of the share acquisition agreement signed by the Company, an amount of 4,828 thousand shares were issued to Noam Yellin in consideration for waiver of the loan in the amount of $ 19,000. |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| b. |  On July 5, 2011 the Company entered into a share purchase agreement (the "Agreement") with Top Alpha Capital, an Israeli corporation, (hereinafter – "Top Alpha") for the issue of 96,613,788 shares of common stock, representing 49.9% of the Company outstanding share capital, for the total consideration of $160,000 ("Transaction"). The purchase price was funded by available funds. As a result of this transaction, balances in the amount of $ 264,000 were deducted from the results of the operations for the year in regard to waiver of debts. |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

----

----

| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|--------------|---------------------------------------------------------------------------------------------|

----

----

----

----

----

----

----

| Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
|--------------|------------------------------------------------------------|

| Item 4T. | Controls and Procedures |
|---------------|-------------------------|

----

| Item 1. | Legal Proceedings |
|--------------|-------------------|

| Item 1A. | Risk Factors |
|---------------|--------------|

| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
|--------------|-------------------------------------------------------------|

| Item 3. | Defaults Upon Senior Securities |
|--------------|---------------------------------|

| Item 4. | [Removed and Reserved] |
|--------------|------------------------|

| Item 5. | Other Information |
|--------------|-------------------|

| Item 6. | Exhibits |
|--------------|----------|

----

|                          |            |  ACRO INC.                                         |
|-------------------------------|-----------------|---------------------------------------------------------|
|                          |            |  (Registrant)                                      |
|                          |            |                                                    |
| Date: November 14, 2011  | By:   | /s/ Asaf Porat                                          |
|                          |            | Asaf Porat                                              |
|                          |            | President, Chief Executive Officer & Director, |
|                          |            | Chief Financial Officer                                 |

----

| Number |   | Description                                                                                                              |   | Method of Filing                                                                                                   |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                     |   |                                                                                                               |
| (3)    |   | Articles of Incorporation and By-laws                                                                                    |   |                                                                                                               |
|   |   |                                                                                                                     |   |                                                                                                               |
| 3.1    |   | Articles of Incorporation, as amended.                                                                                   |   | Incorporated by reference to Exhibit 3.1 to our registration statement on Form SB-2 filed November 21, 2003        |
|   |   |                                                                                                                     |   |                                                                                                               |
| 3.2    |   | Bylaws, dated February 25, 2005.                                                                                         |   | Incorporated by reference to Exhibit 3.1 to our current report on Form 8-K filed March 17, 2005 and March 21, 2005 |
|   |   |                                                                                                                     |   |                                                                                                               |
| 3.3    |   | Certificate of Change Pursuant to NRS 78.209 filed with the State of Nevada effective as of January 25, 2006.            |   | Incorporated by reference to Exhibit 3.3 to our annual report on Form 10-KSB filed March 28, 2007                  |
|   |   |                                                                                                                     |   |                                                                                                               |
| 3.4    |   | Certificate of Change Pursuant to NRS 78.209 filed with the State of Nevada effective as of October 25, 2006.            |   | Incorporated by reference to Exhibit 3.4 to our annual report on Form 10-KSB filed March 28, 2007                  |
|   |   |                                                                                                                     |   |                                                                                                               |
| 3.5    |   | Certificate of Change Pursuant to NRS 78.209 filed with the State of Nevada effective as of October 30, 2006.            |   | Incorporated by reference to Exhibit 3.5 to our annual report on Form 10-KSB filed March 28, 2007                  |
|   |   |                                                                                                                     |   |                                                                                                               |
| (10)   |   | Material Contracts                                                                                                       |   |                                                                                                               |
|   |   |                                                                                                                     |   |                                                                                                               |
| 10.1   |   | Agreement and Plan of Merger for the Merger of ACRO Inc. with and into Medina International Corp., dated April 25, 2006. |   | Incorporated by reference to Exhibit 10.2 to our current report on Form 8-K filed May 4, 2006                      |
|   |   |                                                                                                                     |   |                                                                                                               |
| 10.2   |   | Patent Purchase Agreement between the Registrant and Prof. Ehud Keinan, dated February 1, 2006.                          |   | Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed February 3, 2006                 |
|   |   |                                                                                                                     |   |                                                                                                               |
| 10.3   |   | Consulting Agreement between the Registrant and BioTech Knowledge LLC, dated February 1, 2006.                           |   | Incorporated by reference to Exhibit 10.2 to our current report on Form 8-K filed February 3, 2006                 |
|   |   |                                                                                                                     |   |                                                                                                               |
| 10.4   |   | Letter of Agreement between the Registrant and BioTech Knowledge LLC, dated February 1, 2006.                            |   | Incorporated by reference to Exhibit 10.3 to our current report on Form 8-K filed February 3, 2006                 |
|   |   |                                                                                                                     |   |                                                                                                               |
| 10.5   |   | Advisory Board Agreement between the Registrant and Prof. Richard E. Lerner, dated May 31, 2006.                         |   | Incorporated by reference to Exhibit 99.2 to our current report on Form 8-K filed June 5, 2006                     |
|   |   |                                                                                                                     |   |                                                                                                               |
| 10.6   |   | Advisory Board Agreement between the Registrant and Prof. K. Barry Sharpless, dated September 28, 2006.                  |   | Incorporated by reference to Exhibit 10.8 to our annual report on Form 10-KSB filed March 28, 2007                 |
|   |   |                                                                                                                     |   |                                                                                                               |

----

| 10.7   |   | Consulting Agreement between Acrosec Ltd. and M.G NET Ltd., dated March 26, 2007                                                                                            |   | Incorporated by reference to Exhibit 10.10 to our annual report on Form 10-KSB filed March 28, 2007 |
|--------|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------------------|
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.8   |   | Cooperation and Licensing Agreement between the Registrant and Life Science Research Israel Ltd., dated October 28, 2007.                                                   |   | Incorporated by reference to Exhibit 10.11 to our annual report on Form 10-KSB filed March 13, 2008 |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.9   |   | Intellectual Property Assignment and Services Termination Agreement, dated March 30, 2009.                                                                                  |   | Incorporated by reference to Exhibit 10.12 to our annual report on Form 10-K filed March 30, 2009   |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.10  |   | Convertible Promissory Note between the Registrant and BioTech Knowledge LLC, dated February 22, 2009.                                                                      |   | Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed February 23, 2009 |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.11  |   | Warrant between the Registrant and BioTech Knowledge LLC, dated February 22, 2009.                                                                                          |   | Incorporated by reference to Exhibit 10.14 to our annual report on Form 10-K filed March 30, 2009   |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.12  |   | Convertible Promissory Note between the Registrant and BioTech Knowledge LLC, dated March 24, 2010.                                                                         |   | Incorporated by reference to Exhibit 10.12 to our annual report on Form 10-K filed March 29, 2010   |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.13  |   | Warrant between the Registrant and BioTech Knowledge LLC, dated March 24, 2010.                                                                                             |   | Incorporated by reference to Exhibit 10.13 to our annual report on Form 10-K filed March 29, 2010   |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.14  |   | The Registrant’s 2008 Israeli Share Option Plan                                                                                                                       |   | Incorporated by reference to Exhibit 10.1 to our current report on Form 8-K filed May 1, 2008       |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.15  |   | Finders Agreement between the Registrant and Siden Investment Inc. dated March 13, 2010.                                                                                    |   | Incorporated by reference to Exhibit 10.15 to our annual report on Form 10-K filed March 29, 2010   |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 10.16  |   | Promissory Note between the Registrant and Lindon Group, dated April 1, 2010.                                                                                               |   | Incorporated by reference to Exhibit 10.16 to our quarterly report on Form 10-Q filed May 20, 2010  |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| (31)   |   | Section 302 Certification                                                                                                                                                   |   |                                                                                                |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 31.1   |   | Certification of Principal Executive Officer and Principal Financial Officer Rule 13a-14(a) pursuant to Rule13a- 14(a) of the Securities Exchange Act of 1934.              |   | Filed herewith                                                                                      |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| (32)   |   | Section 906 Certification                                                                                                                                                   |   |                                                                                                |
|   |   |                                                                                                                                                                        |   |                                                                                                |
| 32.1   |   | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, required by Section 906 of the Sarbanes-Oxley Act of 2002. |   | Filed herewith                                                                                      |

----